The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Check out the hybrid joint HMA/EMA multi-stakeholder workshop on Artificial Intelligence (AI) that will be held on 5 November 2024. The objectives of the workshop is to provide an update on the state-of-the-art of AI developments with keynote speakers:

  • Update stakeholders on:
    • policy and legislative environment;
    • HMA/EMA activities on AI.
  • Discuss with stakeholders and experts:
    • progress of the multi-annual AI workplan and possible updates;
    • AI use cases in the medicine lifecycle.

For more information, click the EMA website https://www.ema.europa.eu/en/events/hma-ema-multi-stakeholder-workshop-artificial-intelligence

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

Privacy Policy

info@cddf.org
Tel: +32 2 880 62 70